(Q40687265)

22 September 2017

Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma (English)

1 reference

22 September 2017

1 reference

Bauer C

1

1 reference

22 September 2017

Diesinger I

2

1 reference

22 September 2017

Brass N

3

1 reference

22 September 2017

Steinhart H

4

1 reference

22 September 2017

Iro H

5

1 reference

22 September 2017

Meese EU

6

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

22 September 2017

1 reference

22 September 2017

92

1 reference

22 September 2017

822-829

1 reference

22 September 2017

4

1 reference

Oncogene amplification in tumor cells.

22 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

Antigens recognized by autologous antibody in patients with renal-cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

eIF4G: a multipurpose ribosome adapter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

Oncogenic proteins as tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010815%2992%3A4%3C822%3A%3AAID-CNCR1388%3E3.0.CO%3B2-A

10.1002/1097-0142(20010815)92:4<822::AID-CNCR1388>3.0.CO;2-A

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference